benzonidazole has been researched along with Cerebromeningitis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flash, CA; Goodman, JC; Patel, SM; Stager, CE; Woc-Colburn, L; Yasukawa, K | 1 |
| Bezerra, RC; Buccheri, R; Freitas, VL; Kassab, MJ; Khoury, Z; Shikanai-Yasuda, MA; Silva, SC; Vidal, JE | 1 |
| Alquichire, C; Diazgranados, CA; Franco-Paredes, C; Mantilla, M; Saavedra-Trujillo, CH; Valderrama, SL | 1 |
| Ibrahim, K; Le Loup, G; Malvy, D | 1 |
| de Almeida, LR; de Souza, AS; Lannes-Vieira, J; Moreira, OC; Pereira, IR; Rocha, MS; Silva, AA; Silva, RR; Vilar-Pereira, G | 1 |
| Braz, LM; Gakiya, E; Ibrahim, KY; Lopes, MH; Nunes Westphalen, EV; Oliveira, OC; Sartori, AM; Shikanai-Yasuda, MA | 1 |
| Jardim, E; Takayanagui, OM | 1 |
1 review(s) available for benzonidazole and Cerebromeningitis
| Article | Year |
|---|---|
Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association.
Topics: Adult; Anticonvulsants; Antiretroviral Therapy, Highly Active; Chagas Disease; Female; HIV Infections; Humans; Immunocompromised Host; Meningoencephalitis; Nitroimidazoles; Seizures; Trypanocidal Agents | 2009 |
6 other study(ies) available for benzonidazole and Cerebromeningitis
| Article | Year |
|---|---|
Trypanosoma cruzi meningoencephalitis in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Chagas Disease; Diagnosis, Differential; Female; Humans; Meningoencephalitis; Middle Aged; Nitroimidazoles; Toxoplasmosis, Cerebral; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2014 |
CHAGASIC MENINGOENCEPHALITIS IN AN HIV INFECTED PATIENT WITH MODERATE IMMUNOSUPPRESSION: PROLONGED SURVIVAL AND CHALLENGES IN THE HAART ERA.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Chagas Disease; Female; Humans; Immunosuppressive Agents; Meningoencephalitis; Nitroimidazoles; Secondary Prevention; Survival Rate; Time Factors; Trypanocidal Agents; Ultrasonography | 2015 |
[Chagas disease and immunodeficiency: HIV infection and transplantation].
Topics: Anti-HIV Agents; Chagas Disease; France; HIV Infections; Humans; Meningoencephalitis; Nifurtimox; Nitroimidazoles; Transplantation; Trypanocidal Agents | 2009 |
Trypanosoma cruzi-induced depressive-like behavior is independent of meningoencephalitis but responsive to parasiticide and TNF-targeted therapeutic interventions.
Topics: Animals; Antidepressive Agents, Second-Generation; Chagas Disease; Depression; Emotions; Exploratory Behavior; Female; Fluoxetine; Glial Fibrillary Acidic Protein; Hindlimb Suspension; Immunohistochemistry; Meningoencephalitis; Mice; Mice, Inbred C3H; Motor Activity; Nitroimidazoles; Pentoxifylline; Phenotype; Phosphodiesterase Inhibitors; Psychomotor Performance; Real-Time Polymerase Chain Reaction; Swimming; Trypanocidal Agents; Trypanosoma cruzi; Tumor Necrosis Factor-alpha | 2012 |
Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Brazil; Chagas Cardiomyopathy; Chagas Disease; Chronic Disease; Female; HIV Infections; Humans; Male; Meningoencephalitis; Middle Aged; Nitroimidazoles; Parasitemia; Trypanocidal Agents; Xenodiagnosis | 2007 |
Chagasic meningoencephalitis with detection of Trypanosoma cruzi in the cerebrospinal fluid of an immunodepressed patient.
Topics: Adult; Animals; Cerebrospinal Fluid; Chagas Disease; Humans; Immunocompromised Host; Immunosuppression Therapy; Kidney Transplantation; Male; Meningoencephalitis; Nitroimidazoles; Recurrence; Trypanocidal Agents; Trypanosoma cruzi | 1994 |